Real-Time Identification System of Magnetically Controlled Capsule Endoscopy Using Artificial Intelligence
Launched by CHANGHAI HOSPITAL · Dec 16, 2019
Trial Information
Current as of June 19, 2025
Unknown status
Keywords
ClinConnect Summary
Magnetically controlled capsule endoscopy (MCE) has been used in clinical practice for gastric examination, with high sensitivity and specificity of 90.4% and 94.7%, respectively.
Therefore, a real-time auxiliary system based on convolutional neural network deep learning framework was developed to assist clinicians to improve the quality in MCE examinations.
Patients referred for magnetically controlled capsule endoscopy (MCE) in the participating center were prospectively enrolled. After passage through the esophagus, physician will finish the gastric examination under magnetic steering ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • With or without gastrointestinal complaints
- • Scheduled to undergo a capsule endoscopy for both stomach and small bowel
- • Signed the informed consents before joining this study
- Exclusion Criteria:
- • Dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal stenosis, overt gastrointestinal bleeding, history of upper gastrointestinal surgery or abdominal surgery altering gastrointestinal anatomy
- • Refused abdominal surgery to take out the capsule in case of capsule retention
- • Implanted pacemaker, except the pacemaker is compatible with MRI
- • Other implanted electromedical devices or magnetic metal foreign bodies
- • Pregnancy or suspected pregnancy
About Changhai Hospital
Changhai Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence, the hospital integrates cutting-edge medical technologies and a multidisciplinary approach to patient care. Changhai Hospital actively collaborates with research organizations and healthcare professionals to conduct rigorous clinical trials aimed at developing new treatments and improving patient outcomes. By prioritizing patient safety and ethical standards, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and the enhancement of therapeutic options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
Zhuan Liao
Study Chair
Changhai Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials